Concinnity Genetics at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Concinnity Genetics brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on switches that let a drug turn a gene therapy's expression up or down. The projects build RNA-based control systems and test how well they regulate a transgene.

OrganizationESGCT 2026 Attendance
concinnitygenetics.com
Biotech
Uses an AI design platform and synthetic biology to build RNA-based switches that control gene therapy expression in response to a drug.
Poster
Wed Oct 28
1:30pm–3:30pm
RNA-based, drug-responsive control systems for clinically controllable gene therapies
Other
Vectors and delivery (AAV, lentiviral, LNP)
Poster
Thu Oct 29
2:00pm–4:00pm
Engineering RNA-based control systems for regulation of transgene expression
Other
Vectors and delivery (AAV, lentiviral, LNP)

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Concinnity Genetics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction